What stage does Santen Pharmaceutical invest at?

Santen Pharmaceutical invests at the Series A, Series B, Series C stages.

What sectors does Santen Pharmaceutical focus on?

Santen Pharmaceutical focuses on Biotech, Healthtech, Medical Devices.

Where is Santen Pharmaceutical located?

Santen Pharmaceutical is headquartered in Osaka, JP.

Santen Pharmaceutical

Corporate VC

Osaka · Series A–Series C

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

Santen Pharmaceutical is an Osaka, Japan-based pharmaceutical company specializing in ophthalmology, with operations in about 20 countries and products sold in more than 70. Alongside its core research, development, and commercialization business, it has made corporate venture investments in health-related startups across Series A through Series C rounds.

Invests inBiotech Healthtech Medical DevicesOsaka

Stage

Series A–Series C

Osaka, JP

Instruments

Equity

Tracked investments

Investments · 1 tracked

founders shown can be your intro path

International BioMedical Devices

Frequently asked questions

What stage does Santen Pharmaceutical invest at?: Santen Pharmaceutical invests at the Series A, Series B, Series C stages.
What sectors does Santen Pharmaceutical focus on?: Santen Pharmaceutical focuses on Biotech, Healthtech, Medical Devices.
Where is Santen Pharmaceutical located?: Santen Pharmaceutical is headquartered in Osaka, JP.

Similar investors

ACT Venture Capital

ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.

$1.1M – $16.2M

Avego BioScience Capital

Avego is a healthcare-focused investment firm that partners with entrepreneurs and management teams across private and public companies developing products and services throughout the healthcare continuum. Its Avego BioScience Capital strategy focuses on mid-to-late stage venture financings for biotech companies.

Fluke Venture Partners

Fluke Venture Partners is a Pacific Northwest venture firm that has funded technology, healthcare, and consumer companies for over three decades, working with management teams as long-term partners from early stages onward.

$1M – $4M

Vesalius Biocapital III Partners SàRL

Vesalius Biocapital is a European life sciences venture capital investor focused on later-stage companies in drug development, medical devices and diagnostics, and eHealth/mHealth. Its active fund, Vesalius Biocapital III, closed in May 2019 with €120 million in commitments.